Study of Neuroimaging Biomarkers of Social Cognition Deficits in Adolescents (Age 13-17) With Autism Spectrum Disorder and Effects of Gabapentin

NCT03589898 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Autism Spectrum Disorder

Interventions

DRUG: Gabapentin

Sponsor

University of Massachusetts, Worcester

Collaborators

[object Object]
[object Object]